Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Fleury S.A.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Diagnostics & ResearchSector: Healthcare

Fair Value Summary

Current Price$14.92
5Y Range57.16 – 113.30
5Y Selected85.23
(-) Safety Margin47.55%
5Y Buy Price$46.18
Upside (to Buy Price)209.51%
10Y Range64.70 – 124.76
10Y Selected94.73
(-) Safety Margin47.55%
10Y Buy Price$51.32
Upside (to Buy Price)243.99%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9638
Revenue R2 (10Y)0.8367
Net Income R2 (5Y)0.8013
Net Income R2 (10Y)0.6677
EBITDA R2 (5Y)0.9715
EBITDA R2 (10Y)0.8811
FCF R2 (5Y)0.8547
FCF R2 (10Y)0.7423
Safety Score0.5418

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth10.60%9.87%9.13%8.40%7.67%6.93%6.20%5.47%4.73%4.00%
Revenue8,499.129,337.5810,190.3011,046.1811,892.9612,717.4613,505.8814,244.1514,918.3515,515.09
EBITDA2,576.892,831.103,089.653,349.143,605.883,855.874,094.914,318.754,523.174,704.09
D&A-813.13-893.35-974.93-1,056.81-1,137.83-1,216.71-1,292.14-1,362.77-1,427.27-1,484.36
EBIT1,763.761,937.762,114.722,292.332,468.062,639.162,802.772,955.983,095.893,219.73
Pro forma Taxes-443.66-487.43-531.94-576.62-620.82-663.86-705.01-743.55-778.75-809.90
NOPAT1,320.101,450.331,582.781,715.711,847.241,975.302,097.762,212.432,317.152,409.83
Capital Expenditures-691.08-759.25-828.59-898.18-967.04-1,034.08-1,098.19-1,158.22-1,213.04-1,261.56
NWC Investment-58.46-60.19-61.21-61.44-60.78-59.18-56.59-53.00-48.40-42.84
(+) D&A813.13893.35974.931,056.811,137.831,216.711,292.141,362.771,427.271,484.36
Free Cash Flow1,383.691,524.241,667.901,812.901,957.242,098.742,235.112,363.992,482.992,589.80
Diluted Shares Outstanding544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50544,829,956.50

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 7.39%Terminal Growth: 3.02%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.900.840.780.730.680.630.590.55
PV UFCF1,373.851,475.031,502.921,521.101,529.131,526.781,514.031,491.061,458.281,416.29
Raw: 46,123.50
34,772.05
Raw: 61,030.12
32,206.09

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value42,174.0747,014.56
(-) Net Debt983.08983.08
Equity Value41,190.9946,031.48
(/) Shares Out544.83544.83
Fair Value$75.60$84.49
(-) Safety Margin47.55%47.55%
Buy Price$39.65$44.31
Current Price$14.92$14.92
Upside (to Buy Price)165.78%197.01%

Conservative Projected Flows

WACC: 8.39%Terminal Growth: 2.52%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.820.760.700.640.590.550.51
PV UFCF1,372.581,468.751,482.721,486.811,480.871,464.951,439.321,404.411,360.861,309.48
Raw: 34,174.12
24,835.08
Raw: 45,218.83
21,960.76

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value32,126.8136,231.51
(-) Net Debt983.08983.08
Equity Value31,143.7335,248.43
(/) Shares Out544.83544.83
Fair Value$57.16$64.70
(-) Safety Margin47.55%47.55%
Buy Price$29.98$33.93
Current Price$14.92$14.92
Upside (to Buy Price)100.95%127.43%

Aggressive Projected Flows

WACC: 6.39%Terminal Growth: 3.52%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.910.860.810.760.710.670.630.59
PV UFCF1,375.141,481.391,523.591,556.511,579.431,591.831,593.371,583.951,563.691,532.93
Raw: 70,555.88
55,198.86
Raw: 93,358.78
53,573.76

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value62,714.9168,955.60
(-) Net Debt983.08983.08
Equity Value61,731.8467,972.52
(/) Shares Out544.83544.83
Fair Value$113.30$124.76
(-) Safety Margin47.55%47.55%
Buy Price$59.43$65.44
Current Price$14.92$14.92
Upside (to Buy Price)298.31%338.58%

Reverse DCF: Market Implied Growth

Current Price$14.92
WACC Used7.4%
IMPLIED REVENUE GROWTH100.73%
Metric2027202820292030203120322033203420352036
Implied Revenue16,198.9532,516.5565,271.26131,020.57263,000.77527,927.811,059,722.272,127,206.184,269,992.498,571,259.34
Constant Implied Growth100.73%100.73%100.73%100.73%100.73%100.73%100.73%100.73%100.73%100.73%
Implied Free Cash Flow1.623.256.5313.1026.3052.79105.97212.72427.00857.13
Discount Factor0.940.840.780.730.680.630.590.550.510.47
Present Value of Implied FCF1.532.735.109.5317.8233.3062.24116.33217.44406.41

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$22.6410.76%$30.1733.27%
20182018-12-31$14.2112.69%$25.3578.42%
20172017-12-31$27.9213.01%$16.16-42.11%
20162016-12-31$11.9410.80%$24.03101.29%
20152015-12-31$5.018.62%$15.48208.89%
20142014-12-31$5.0710.61%$10.38104.80%
20132013-12-31$5.2811.30%$3.18-39.68%
20122012-12-31$6.299.34%$-0.86-113.65%
20112011-12-31$5.917.99%$-3.19-154.02%
20102010-12-31$7.288.67%$5.78-20.56%
20092009-12-31$4.9312.06%$0.31-93.71%
20082008-12-31$4.8914.74%$-1.45-129.65%
20072007-12-31$4.8914.79%$-1.59-132.57%
20062006-12-31$4.8915.01%$4.58-6.44%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$91.01
Median
$84.34
10th Percentile
$64.57
90th Percentile
$124.11

Fair Value Distribution

$45.01 - $64.26
94
$64.26 - $83.51
393
$83.51 - $102.75
285
$102.75 - $122.00
119
$122.00 - $141.25
49
$141.25 - $160.50
30
$160.50 - $179.74
14
$179.74 - $198.99
6
$198.99 - $218.24
4
$218.24 - $237.49
2
$237.49 - $256.73
1
$256.73 - $275.98
1
$275.98 - $295.23
0
$295.23 - $314.48
1
$314.48 - $333.72
0
$333.72 - $352.97
0
$352.97 - $372.22
0
$372.22 - $391.47
0
$391.47 - $410.72
0
$410.72 - $429.96
1